Cytokine status in patients with ST-segment elevation myocardial infarction and carbohydrate metabolism disorders

• Seseg S. Tsyretorova

Abstract

The paper is dedicated to the study of the nature of the inflammatory response in patients with acute ST-segment elevation myocardial infarction (STEMI) and type 2 diabetes mellitus (T2DM), impaired glucose tolerance/impaired fasting glycemia (IGT/IFG). Analysis of the results showed a marked increase in the levels of interleukin‑1β, interleukin‑6, and interleukin‑10 in patients with both T2DM and STEMI, as well as IGT/IFG and STEMI relative to the control group.

Keywords:diabetes mellitus; myocardial infarction; inflammation; cytokines

References

1. International Diabetes Federation. IDF Diabetes Atlas. 10^th ed. 2021.

2. Dedov I.I., Shestakova M.V., Vikulova O.K., et al. Epidemiological characteristics of diabetes mellitus in the Russian Federation: clinical and statistical analysis according to the Federal diabetes register data of 01.01.2021. Sakharni diabet [Diabetes Mellitus]. 2021; 24 (3): 204–21. (in Russian)

3. Laichuthai N., Abdul-Ghani M., Kosiborod M., et al. Newly discovered abnormal glucose tolerance in patients with acute myocardial infarction and cardiovascular outcomes: a meta-analysis. Diabetes Care. 2020; 8: 1958–66.

4. Lee J., Lee S., Zhang H., Hill M.A., et al. Interaction of IL‑6 and TNF-α contributes to endothelial dysfunction in type 2 diabetic mouse hearts. PLoS One. 2017; 12 (11): 0187189.

5. Kalinskaya A., Dukhin O., Lebedeva A., et al. Circulating cytokines in myocardial infarction are associated with coronary blood flow. Front Immunol. 2022; 13: 837642.

All articles in our journal are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0 license)